GJA1 and cardiomyopathy: Treatment with S-diclofenac, but not diclofenac, not only remarkably upregulated the cardiac expression of Cxs (Cx43 and Cx45) mRNA and proteins, but also raised the density and length of gap junctions in doxorubicin-induced cardiomyopathy.